MedTrace Logo

Hormone Deficiency After Brain Injury During Combat

NCT01666964 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-08-16

No results posted yet for this study

Summary

We would like to ascertain the prevalence of hypopituitarism after combat-related TBI. This will lead to enhanced awareness, recognition, and treatment of hypopituitarism, which can have life-saving ramifications and enhance quality of life and rehabilitation efforts in our combat veterans.

Conditions

Interventions

OTHER

Blast Traumatic Brain Injury

Exposure during combat to blast-wave mediated Traumatic Brain Injury

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Walter Reed National Military Medical Center

    lead FED

Principal Investigators

  • Andrew J. Brackbill, M.D. · WalterReed National Military Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01666964 on ClinicalTrials.gov